Microrobots move closer to precision medicine after two decades of progress
Journal Center of Harbin Institute of Technology
image:
This figure illustrates a magnetic microrobot system for targeted drug delivery. A catheter or endoscope delivers a microrobotic assembly close to the target tissue, after which magnetic navigation guides the microrobots through the vasculature. The system is designed to disassemble into a microrobotic swarm, release therapeutics locally, and then undergo degradation or clearance.
view moreCredit: 2026 The Author(s). SmartBot published by John Wiley & Sons Australia, Ltd on behalf of Harbin Institute of Technology. Figure courtesy of Minsoo Kim, as stated in the original figure legend.
Imagine a medical machine small enough to travel through blood vessels, navigate toward diseased tissue, release a therapeutic payload, and then degrade or be cleared from the body. Microrobots, generally ranging from about a millimeter down to a few microns in size, are designed to operate in confined and complex environments that are inaccessible to conventional robotic systems. Inspired by the motility and adaptability of microorganisms, these systems are being investigated for highly localized biomedical tasks, including targeted drug delivery, minimally invasive diagnosis, microsurgery, and cell- or tissue-level therapeutic intervention. The perspective article places this development within the broader scientific foundations of microscale engineering, including early concepts of nanoscale manipulation and the physical principles governing motion at low Reynolds number.
A central challenge in microrobotics is that microscale motion is governed by physical rules that differ fundamentally from those at the macroscale. In low-Reynolds-number environments, viscous forces dominate while inertial effects become negligible, causing motion to stop almost immediately once external actuation is removed. Under these conditions, reciprocal motions cannot generate net propulsion, as described by Purcell’s scallop theorem. Microrobots must therefore rely on locomotion strategies that break time-reversal symmetry or exploit external fields, responsive materials, or biological propulsion mechanisms. Brownian motion, surface interactions, and limited onboard energy storage further constrain microrobot operation, making it necessary to integrate propulsion, sensing, and control through carefully designed structures and materials.
The article reviews several propulsion mechanisms that have shaped the field. Chemical propulsion, such as catalytic bubble-driven motion, provided early demonstrations of autonomous microscale locomotion, although biomedical translation remains limited by concerns regarding fuel toxicity and biocompatibility. Acoustic propulsion offers a noninvasive strategy for manipulating individual microrobots or swarms through ultrasonic fields, but its spatial precision may be lower than that of magnetic systems. Optical propulsion is effective in transparent or semi-transparent environments, yet its in vivo use is constrained by limited tissue penetration. Biohybrid propulsion, based on motile cells such as bacteria or sperm, offers biological adaptability but raises challenges related to immunogenicity, stability, and controllability. Among these approaches, magnetic actuation is identified as particularly promising for clinical applications because magnetic fields can penetrate biological tissues, be dynamically controlled, and integrate with existing medical imaging technologies.
Progress in microrobotics also depends on advances in fabrication, functional materials, and embodied intelligence. Techniques such as two-photon polymerization, microelectromechanical systems, self-assembly, and nanofabrication have enabled complex microrobot geometries, including helices, cages, artificial cilia, and other biomimetic architectures. Material selection is equally important: biodegradable polymers may reduce the need for retrieval after treatment, stimuli-responsive hydrogels can enable environment-triggered functions, and surface modifications may improve biocompatibility or reduce immune recognition. Because conventional processors, batteries, and communication modules are difficult to miniaturize, intelligence at the microscale is often encoded directly into the robot’s geometry, material composition, or collective behavior. For example, helical structures can convert rotating magnetic fields into forward propulsion, while microrobot swarms may support distributed tasks such as collective transport, broad-area sensing, or localized therapeutic delivery.
The most immediate and potentially transformative applications of microrobots are expected in medicine. The article highlights intravascular navigation, targeted drug delivery, tumor therapy, localized antibiotic delivery, microscale biopsy, chemical sensing, and soft microrobot navigation through tortuous biological pathways as key areas of development. Magnetic microrobots are of particular interest for delivering clot-dissolving drugs in stroke treatment and for transporting therapeutic agents directly to disease sites while reducing systemic exposure.
Nevertheless, significant translational barriers remain, including wireless power supply, communication, real-time imaging, closed-loop control, scalable manufacturing, regulatory approval, retrieval or degradation strategies, long-term safety, and ethical acceptance. Looking ahead, the article suggests that the next stage of microrobotics will depend on combining biocompatible materials, high-resolution imaging, AI-driven control, and clinically compatible navigation systems. If these challenges can be addressed, early clinical directions are likely to focus on life-threatening conditions such as stroke and cancer, where targeted delivery and minimally invasive intervention could offer major benefits. Over time, microrobots may become practical tools of precision medicine, performing diagnostic and therapeutic tasks at scales invisible to the human eye but potentially transformative for human health.
Journal
SmartBot
Article Title
Microrobots: Two Decades of Progress
Article Publication Date
20-May-2026
COI Statement
The Editor-in-Chief Bradley J. Nelson is an author of this manuscript. To avoid any potential conflict of interest, he took no part in the editorial decision-making or peer-review process for this submission, which was handled entirely by an independent editor/the editorial office. The author declares no other conflicts of interest.